bims-traimu Biomed News
on Trained immunity
Issue of 2026–11–08
thirteen papers selected by
Yantong Wan, Southern Medical University



  1. Trends Immunol. 2026 Nov 04. pii: S1471-4906(26)00293-0. [Epub ahead of print]
      Trained immunity describes the capacity of innate immune cells to develop memory-like responses following a prior challenge. Early studies focused on myeloid cells and bone marrow progenitors. Extension of this concept to mucosal tissues, however, presents a more complex picture. These barrier sites harbor diverse, long-lived immune populations that interact with structural cells and neuronal circuits to actively shape immune responses. Emerging evidence suggests that memory-like programs extend beyond immune cells to include epithelial, stromal, and neuronal compartments. We propose that trained immunity in mucosal surfaces is distributed across the tissue ecosystem, encompassing progenitors, tissue-resident populations, and the tissue niche. This expanded framework redefines innate immune memory and has important implications for infections and chronic inflammatory diseases.
    Keywords:  imprinting; innate; innate lymphoid cells; memory; priming
    DOI:  https://doi.org/10.1016/j.it.2026.10.003
  2. Nat Commun. 2026 Oct 08. pii: 11460. [Epub ahead of print]17(1):
      Adaptive immune memory generated by bacterial toxin vaccination is well established, but whether bacterial toxins can also induce innate immune memory, or trained immunity (TI), remains unclear. Here, we show that bacterial toxins elicit TI through NLRP3 inflammasome activation both in vitro and in vivo in mice, and that this response is conserved in primary human macrophages. Stimulation with the CNF1 toxin induced an epigenetic remodeling, defining a TI-associated transcriptional signature. A targeted RNAi screen identified Bcl2a1 as a required mediator of TI, and epistasis analyses demonstrated that IL-1 signaling is essential for TI induction in macrophages. In our mouse sepsis model, toxin-induced TI enhanced host resistance and improved survival. These findings establish toxin-driven inflammasome activation as trigger of transient TI and demonstrate that this response enhance resistance during experimental bacterial sepsis.
    DOI:  https://doi.org/10.1038/s41467-026-78499-5
  3. Cell Rep. 2026 Nov 04. pii: S2211-1247(26)01342-2. [Epub ahead of print]45(11): 118263
      Epidemiological evidence linking asthma to lung cancer risk remains contradictory, presenting asthma as either a risk factor or a protective condition. We hypothesize that this heterogeneity stems from the temporal dynamics of inflammatory response and host genetic background. Using ovalbumin (OVA)-induced asthma models, we identify a temporal shift in immune effectors driving post-asthmatic tumorigenesis. During acute airway inflammation, eosinophil infiltration accelerates tumor growth across mouse strains. Following resolution, however, tumorigenic outcomes in recovery diverge along genetic lines. Prior asthma reshapes chromatin landscapes of bone marrow myeloid progenitors, establishing innate immune memory that differentially programs monocytes across strains. In C57BL/6 mice, trained monocytes adopt oxidative phosphorylation (OXPHOS), acquiring a suppressive, tissue-remodeling phenotype that promotes tumor progression. Conversely, BALB/c-trained monocytes utilize glycolysis to maintain a pro-phagocytic state, enabling tumor clearance. These findings delineate a biphasic mechanism wherein temporal shifts in post-asthmatic immune responses define tumor outcomes via strain-specific monocyte metabolic reprogramming.
    Keywords:  CP: cancer; CP: immunology; asthma; immunogenetic heterogeneity; lung tumorigenesis; monocyte reprogramming; trained immunity
    DOI:  https://doi.org/10.1016/j.celrep.2026.118263
  4. Cell Rep. 2026 Nov 02. pii: S2211-1247(26)01308-2. [Epub ahead of print]45(11): 118229
      The protective adaptation of innate immune defenses against respiratory pathogens has been linked to previous exposure to immune stimuli; however, the underlying mechanisms of these adaptations are not yet fully understood. Here, we show that pre-exposure to a low dose of non-specific immune stimuli or infection protects against subsequent lethal methicillin-resistant Staphylococcus aureus (MRSA) challenge. This enhanced protection concurs with increased alveolar macrophages (AMs) resulting from a self-renewal process in the lungs. Importantly, these AMs are programmed to acquire neutrophil-released antimicrobial enzymes from the extracellular space to clear MRSA, prevent tissue damage, and rapidly restore lung homeostasis. AM function depends on differential gene expression, including expression of the efferocytosis receptor Mer proto-oncogene tyrosine kinase (MerTK) and the anti-apoptotic regulator Bcl-xL. Thus, our data highlight that AMs acquire neutrophil enzymes as an integral component of innate immune adaptation.
    Keywords:  CP: immunology; NETs; efferocytosis; neutrophil extracellular traps; pro-survival Bcl-2 family; trained immunity
    DOI:  https://doi.org/10.1016/j.celrep.2026.118229
  5. Front Immunol. 2026 ;17 1935682
      Inflammatory bowel disease (IBD), comprising Crohn's disease and ulcerative colitis, is a chronic relapsing intestinal inflammatory disorder. Cardiovascular disease (CVD) is a leading cause of death in patients with IBD, with elevated risks of myocardial infarction, heart failure, stroke, and venous thromboembolism that are independent of traditional risk factors. Disease activity and histological inflammation independently predict major adverse cardiovascular events, and Crohn's disease and ulcerative colitis differ in cardiovascular risk profiles. This residual risk points to immune mechanisms that remain unclear. Trained immunity (TI), an innate immune memory induced by epigenetic and metabolic reprogramming, may link chronic intestinal inflammation to cardiovascular injury. This review integrates epidemiological and mechanistic evidence, outlines cardiovascular risk features in IBD, examines the molecular basis of TI and its roles in atherosclerosis, myocardial injury, and heart failure, and evaluates candidate biomarkers and targeted therapeutic strategies. We also discuss current limitations and challenges in clinical translation and propose future research directions, to inform mechanistic studies and clinical interventions for IBD-associated CVD.
    Keywords:  atherosclerosis; cardiovascular disease; epigenetics; inflammatory bowel disease; innate immune memory; trained immunity
    DOI:  https://doi.org/10.3389/fimmu.2026.1935682
  6. JCI Insight. 2026 Nov 03. pii: e198461. [Epub ahead of print]
      Children and adults living with obesity have more severe influenza A virus (IAV) infection, but the underlying mechanisms are unclear. Natural killer (NK) cells play a key role in the innate immune responses to IAV and clearance of IAV-infected cells. 'Trained immunity' of NK cells (and other innate immune cells) refers to an initial stimulus (i.e. obesity) inducing metabolic and epigenetic changes that make these cells hyperinflammatory upon restimulation (i.e. with IAV). Here, we tested whether obesity in children induces trained immunity in NK cells. We have show that NK cells from children with obesity have a hyperinflammatory 'trained' phenotype, with increased expression of activation markers TLR2, CCR2, TLR4, HLA-DR and CD11b compared to children without obesity. Furthermore, we have demonstrate that NK cells from children with obesity have a heightened ex vivo IFN-γ response to stimulation with IAV (A/Auckland/4/2009, H1N1 and HKx31, H3N2) and epigenetic changes consistent trained immunity. A decrease in BMI z-score following weight-management was not associated with a reduction in the IFN-γ response, suggesting that weight loss is not sufficient to normalise NK cell function. Better understanding of obesity-related immune modulation is critical for development of new therapeutic strategies and improving outcomes in future IAV pandemics.
    Keywords:  Immunology; Infectious disease; Influenza; Innate immunity; Obesity
    DOI:  https://doi.org/10.1172/jci.insight.198461
  7. Front Immunol. 2026 ;17 1985821
      CD64 (FcγRI) is traditionally categorized as the high-affinity receptor for immunoglobulin G (IgG) and as a downstream effector of adaptive humoral responses for myeloid-driven clearance and immune programs. Accumulating evidence in myeloid cell biology, however, highlights a major historical oversight: CD64 also operates as a multimodal innate immunoreceptor capable of antibody-independent pattern recognition receptor (PRR) behavior. Synthesizing over three decades of data, this review spotlights the direct interaction of CD64 with humoral pentraxins and microbial outer membrane structures independent of IgG opsonization. We consolidate the biological mechanisms by which CD64 functions as an opsonin receptor or a direct PRR to drive phagocytosis and immune signaling pathways. Because trained immunity is antibody-independent, we introduce an unaddressed paradigm for how CD64 utilizes its non-classical, primordial PRR identity to guide myeloid cells to establish and maintain innate immune memory. This framework resolves a profound evolutionary and teleological conundrum: why frontline myeloid lineages constitutively express and exponentially upregulate CD64 days before pathogen-specific antibodies are manufactured, leveraging an ancient, non-specific pattern-sensing scaffold. Finally, we conceptualize the multi-tiered regulation of CD64 as a precise, localized translational target and predictive biomarker to safely bypass the potential risks of global metabolic and epigenetic therapies.
    Keywords:  C-reactive protein (CRP); CD64/FcγRI; NF-κB; epigenetics; innate immune memory; metabolism; pattern recognition receptor (PRR); pentraxin (PTX)
    DOI:  https://doi.org/10.3389/fimmu.2026.1985821
  8. Front Immunol. 2026 ;17 1999531
       Background: Paediatric asthma exhibits marked clinical heterogeneity and cannot be simply considered the childhood counterpart of adult asthma. Early-life environmental exposures can reshape immune-cell metabolic programs and potentially drive long-lasting inflammatory phenotypes. Existing explanatory frameworks for paediatric asthma largely centre on Th2-related inflammation, epithelial-alarm signalling and neuro-immune crosstalk, while the contributions of immunometabolic processes to disease endotypes remain under-summarised.
    Objective: This review collates available evidence regarding metabolic reprogramming in the pathogenesis of paediatric asthma and provides an integrated immunometabolic perspective on this condition.
    Results: Summarized evidence covers immunometabolic changes across key airway-resident and infiltrating cell populations. Discussion addresses core paediatric-specific biological features, including early-life developmental windows, virus-related trained immunity, obese asthma, circadian-sleep interactions, neuro-metabolic-immune communication and metabolomics-based endotyping. The framework is organized around substrate competition rather than a glycolysis-versus-OXPHOS binary, because Tregs, M2-like macrophages and pathogenic ILC2s share lipid and amino-acid pools but exert opposing functions. From these observations emerges a testable "Metabolic Latching Model" of how early-life insults establish persistent inflammatory memory through metabolism-epigenetic coupling, with "latching" operationally defined by exposure removal and persistence beyond responding-cell turnover. Group 2 innate lymphoid cells (ILC2s) and the Treg-to-effector balance are placed at the centre of this framework. Three hypotheses are prioritised as feasible with current technology: H1 (monocyte glycolytic baseline predicting wheeze-to-asthma transition), H4 (metabolic intervention in obese asthma), and H6 (the HDAC2-GSH/butyrate axis in steroid sensitivity).
    Conclusion: Current evidence suggests that immunometabolic reprogramming serves as one plausible contributing factor for the heterogeneity of paediatric asthma. This conceptual framework may bridge molecular metabolic findings and paediatric clinical contexts, and inform future mechanistic and clinical studies in this research area.
    Keywords:  endotype; ferroptosis; glucocorticoid resistance; immunometabolism; metabolic reprogramming; obese asthma; pediatric asthma; trained immunity
    DOI:  https://doi.org/10.3389/fimmu.2026.1999531
  9. Front Syst Biol. 2026 ;6 1955135
       Background: Macrophages respond dynamically to environmental and tissue-derived stressors, but the extent to which these responses constitute persistent environmental memory remains unclear. Studies of trained immunity, epigenetic regulation, non-coding RNAs, transposable elements, extracellular vesicles (EVs), and immunometabolism suggest multiple mechanisms that may contribute to persistent macrophage states, yet these fields have largely developed independently. We therefore systematically evaluated evidence for macrophage environmental memory and used the resulting evidence base to develop the Macrophage Environmental Memory Systems (MEMS) Framework.
    Methods: A PRISMA-guided systematic review of PubMed and Web of Science was completed on 1 August 2026. Searches identified 1,405 records; after removal of 404 duplicates, 1,001 unique records underwent screening. Following title/abstract screening and final evidence audit, 119 primary studies were included. Studies were classified as Direct when a prior stressor induced a macrophage or monocyte molecular or functional state that persisted after removal of the initiating stimulus, was maintained over time or through cell division, or altered the response to a subsequent challenge; Mechanistic when they demonstrated a relevant macrophage or monocyte mechanism without directly establishing persistence or recall; or Contextual when they provided broader mechanistic support. Studies were assigned to six non-mutually exclusive MEMS modules.
    Results: Of the 119 included studies, only 4 met the stringent criteria for Direct evidence, whereas 50 were Mechanistic and 65 Contextual, revealing a substantial gap between the extensive literature describing environmentally responsive macrophage mechanisms and evidence directly demonstrating persistent environmental memory. Module assignments overlapped and included transposable element regulation (n = 107), metabolic and signaling reprogramming (n = 86), epigenetic regulation (n = 33), systems integration (n = 17), non-coding RNA regulation (n = 14), and EV-mediated communication (n = 7). The evidence therefore identifies numerous candidate mechanisms that may contribute to the acquisition, maintenance, integration, or communication of persistent macrophage states, while demonstrating that direct evidence of persistence remains limited.
    Conclusion: The available literature provides broad mechanistic support for biological processes potentially relevant to macrophage environmental memory but comparatively little direct evidence of persistence or altered subsequent responses. The resulting MEMS Framework organizes this heterogeneous evidence into six interacting molecular systems and is proposed as an evidence-organizing and hypothesis-generating framework rather than a validated six-component biological pathway. Prospective exposure-withdrawal, longitudinal, lineage-tracing, perturbational, and rechallenge studies are needed to determine which mechanisms causally establish and maintain persistent macrophage states. The Macrophage-Mediated Molecular Memory (M3) hypothesis represents a downstream, experimentally testable extension of MEMS involving potential communication of environmentally acquired molecular information and remains distinct from evidence establishing the MEMS Framework itself.
    Keywords:  MEMS; environmental memory; epigenetics; extracellular vesicles; immunometabolism; macrophages; non-coding RNA; systems immunology
    DOI:  https://doi.org/10.3389/fsysb.2026.1955135
  10. Adv Sci (Weinh). 2026 Nov 03. pii: e78586. [Epub ahead of print]
      Sepsis-related cytokine storm is associated with poor prognosis in septic patients. IFNγ/LPS can synergistically trigger a sepsis-associated proinflammatory cytokine storm and induce macrophage death in the form of PANoptosis. The ensuing release of proinflammatory cytokines further amplifies macrophage death, leading to subsequent multiple organ damage. Concurrently, the IFNγ/LPS induced inflammatory cascade also downregulates chaperone-mediated autophagy (CMA) activity, and this dysregulation further exacerbates the inflammatory response in macrophages and in vivo. Thus, a positive feedback loop between dysfunctional CMA and the inflammatory cascade is established. Enhancing CMA activation reduces macrophage death and organ damage, whereas inhibiting CMA exacerbates macrophage PANoptosis and organ injury. Mechanistically, impaired CMA leads to accumulation of the transcription factor CUX1, which subsequently upregulates Pyrin expression and promotes Pyrin-mediated PANoptosome assembly, thereby driving macrophage PANoptosis. In addition to the cytokine storm, the lacylation at lysine 561 (K561) of HSC70, a core component of the CMA machinery, is associated with reduced CMA activity. Blocking lactylation can similarly attenuate macrophage death and multiple organ injury in sepsis. Taken together, this "Kla-CMA-CUX1/Pyrin-PANoptosis" signaling axis, linking metabolic reprogramming to immune dysregulation in sepsis, suggests that targeting key nodes of this axis may represent a promising therapeutic strategy to reduce sepsis-associated mortality.
    Keywords:  CMA; PANoptosis; lysine lactylation; macrophage; sepsis
    DOI:  https://doi.org/10.1002/advs.78586
  11. Inflammation. 2026 Aug 08. pii: 213. [Epub ahead of print]49(1):
      Noncanonical inflammasome activation mediated by caspase-11 drives macrophage pyroptosis and inflammatory amplification in sepsis, but endogenous restraining mechanisms remain incompletely understood. Here, we investigated the role of Nur77 (NR4A1) in cytosolic LPS-induced pyroptotic signaling using RAW264.7 macrophages and an early cecal ligation and puncture (CLP) sepsis model. LPS priming followed by cytosolic LPS stimulation increased Nur77 expression, caspase-11 cleavage, GSDMD processing, lactate dehydrogenase release, and IL-1β release. Nur77 knockdown aggravated membrane damage, increased GSDMD-N generation and pyroptosis-associated cells, and enhanced IL-1β and IL-18 release. Conversely, Nur77 overexpression attenuated caspase-11/GSDMD-associated readouts and reduced pyroptosis-associated injury. This stimulation condition also increased pannexin-1 and P2 × 7 expression, extracellular ATP release, and Yo-PRO-1 uptake; and these changes were amplified by Nur77 deficiency and blunted by Nur77 overexpression. Wedelolactone treatment attenuated caspase-11-associated readouts and was accompanied by reduced pannexin-1/P2 × 7-related responses. In vivo, pharmacological modulation of Nur77 in the early CLP model was associated with corresponding changes in systemic IL-1β/IL-18 levels, lung, liver, and kidney injury, and caspase-11/GSDMD-associated readouts. Collectively, these findings support a model in which Nur77 acts as an endogenous negative modulator of caspase-11/GSDMD-associated pyroptotic signaling and inflammatory amplification during early sepsis.
    Keywords:  Caspase-11; NR4A1/Nur77; Noncanonical inflammasome; Pyroptosis; Sepsis
    DOI:  https://doi.org/10.1007/s10753-026-02568-6
  12. Crit Care. 2026 Aug 01. pii: 563. [Epub ahead of print]30(1):
       BACKGROUND: Sepsis is a highly heterogeneous syndrome characterized by variable immune dysregulation states, including hyperinflammation and immunosuppression. Previous immunotherapy attempts in sepsis have largely failed, likely due to a "one-size-fits-all" approach that ignores each patient's immune status. The recent ImmunoSep randomized clinical trial demonstrated that precision immunotherapy guided by the presence of either macrophage activation-like syndrome (MALS) or immune paralysis can improve early organ dysfunction in sepsis patients. However, the molecular mechanisms underlying these immune endotypes remain unclear.
    OBJECTIVES: To identify the immunological signatures that distinguish MALS and immune paralysis.
    METHODS: We used single-cell RNA sequencing to profile circulating leukocytes of 6 healthy controls and 16 sepsis patients classified as MALS, immune paralysis or unclassified (when criteria for neither of these two immune endotypes were applicable). Classification was based on surrogate biomarkers ferritin and HLA-DR expression on monocytes. Thereafter, the transcriptional programs of these groups were compared.
    RESULTS: Pronounced differences were detected mainly in the transcriptional signature of monocytes from these patients, with a clear distinction between MALS and immune paralysis. Unsupervised clustering analysis revealed the existence of MALS-specific monocyte clusters, as well as one sepsis-specific monocyte cluster that was linked to greater comorbidity burden and may reflect increased clinical vulnerability in sepsis. These findings were validated in two independent cohorts, in which urosepsis was characterized by heterogeneous MALS and immune paralysis monocyte signatures. Moreover, MALS-specific monocyte clusters showed overlapping transcriptional signatures with severe COVID-19.
    CONCLUSIONS: Our findings shed light on the heterogeneous immune landscape underlying sepsis and provide opportunities for patient stratification for future therapeutic development.
    Keywords:  Hyperinflammation; Immune paralysis; Sepsis; Single-cell RNA sequencing
    DOI:  https://doi.org/10.1186/s13054-026-06229-w
  13. Free Radic Biol Med. 2026 Nov 04. pii: S0891-5849(26)01250-5. [Epub ahead of print]
      Sepsis-associated acute lung injury (SALI) is characterized by overwhelming inflammation and oxidative stress, during which damage-associated molecular patterns (DAMPs) exacerbate tissue injury. Peroxiredoxin 1 (PRDX1), a canonical intracellular antioxidant enzyme, paradoxically functions as a pro-inflammatory DAMP after extracellular release. This pathogenic transition depends on PRDX1 dimerization through intermolecular disulfide bonds. However, the endogenous metabolic mechanisms that restrain PRDX1 release remain unclear. Here, we identify the ACOD1-itaconate axis as a critical suppressor of PRDX1-mediated hyperinflammation in SALI. Clinical dataset analysis revealed that elevated PRDX1 expression strongly correlates with sepsis mortality. In a murine cecal ligation and puncture (CLP) model, Acod1 deficiency exacerbated SALI and amplified PRDX1 secretion, whereas therapeutic administration of 4-octyl itaconate (4-OI) robustly alleviated lung injury and the accompanying cytokine storm. Mechanistically, chemical proteomics and mutagenesis showed that itaconate directly targets PRDX1. Acting as an electrophile, itaconate covalently alkylates the highly conserved cysteine 173 residue of PRDX1 via Michael addition. This redox modification sterically blocks intermolecular disulfide bond formation, thereby preventing PRDX1 dimerization and subsequent secretion from primary macrophages. Consequently, the loss of extracellular PRDX1 dimers reduces Toll-like receptor 4 (TLR4) engagement and suppresses downstream MAPK and NF-κB signaling cascades. Strikingly, the PRDX1-C173S loss-of-function mutation abolished the inhibitory efficacy of 4-OI, confirming Cys173 as an indispensable pharmacological target. Together, our study bridges immunometabolism and redox biology by demonstrating that itaconate restrains systemic inflammation through covalent trapping of PRDX1 in a monomeric state, providing a targeted redox-based therapeutic strategy for acute inflammatory diseases.
    Keywords:  ACOD1; Alkylation; Itaconate; Peroxiredoxin 1; Sepsis-induced acute lung injury
    DOI:  https://doi.org/10.1016/j.freeradbiomed.2026.11.007